Fiduciary Alliance’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.39M Buy
5,517
+1,503
+37% +$456K 0.16% 156
2026
Q1
$1.06M Buy
4,014
+239
+6% +$53.4K 0.06% 255
2025
Q4
$646K Buy
3,775
+137
+4% +$21.3K 0.04% 301
2025
Q3
$487K Buy
3,638
+390
+12% +$41.3K 0.03% 348
2025
Q2
$316K Buy
+3,248
New +$258K 0.02% 387
2023
Q3
Sell
-120
Closed -$7.71K 616
2023
Q2
$7.71K Buy
+120
New +$6.76K ﹤0.01% 615
2023
Q1
Sell
-20
Closed -$841 549
2022
Q4
$841 Buy
+20
New +$837 ﹤0.01% 800

Other funds holding LRCX

Fiduciary Alliance's LRCX Position: Q2 2026 in Review

Fiduciary Alliance increased its Lam Research (LRCX) stake by 37% in Q2 2026, buying an estimated $456K and bringing the position to 5,517 shares worth $2.39M. The position accounts for 0.16% of the portfolio, ranked #156.

Fiduciary Alliance first reported a position in LRCX in Q4 2022 and has held it in 7 quarters since. 988 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Fiduciary Alliance held 5,517 shares of Lam Research worth $2.39M as of Q2 2026.
  • Fiduciary Alliance bought 1,503 Lam Research shares in Q2 2026, an estimated $456K.
  • Lam Research made up 0.16% of Fiduciary Alliance's portfolio in Q2 2026, its #156 holding.
  • Fiduciary Alliance first reported a position in Lam Research in Q4 2022 and has held it in 7 quarters since.
  • 988 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Fiduciary Alliance's 13F filing for Q2 2026, filed 20 Jul 2026.